HUP9901208A2 - (R)-5-Bróm-n-(1-etil-4-metil-hexahidro-1H-1,4-diazepin-6-il)-2-metoxi-6-(metil-amino)-3-piridin-karboxamid, eljárás előállítására és ezt a vegyületet tartalmazó gyógyászati készítmény - Google Patents
(R)-5-Bróm-n-(1-etil-4-metil-hexahidro-1H-1,4-diazepin-6-il)-2-metoxi-6-(metil-amino)-3-piridin-karboxamid, eljárás előállítására és ezt a vegyületet tartalmazó gyógyászati készítményInfo
- Publication number
- HUP9901208A2 HUP9901208A2 HU9901208A HUP9901208A HUP9901208A2 HU P9901208 A2 HUP9901208 A2 HU P9901208A2 HU 9901208 A HU9901208 A HU 9901208A HU P9901208 A HUP9901208 A HU P9901208A HU P9901208 A2 HUP9901208 A2 HU P9901208A2
- Authority
- HU
- Hungary
- Prior art keywords
- same
- methylhexahydro
- diazepin
- carboxamide
- bromo
- Prior art date
Links
- FKDXBULKZKICQO-LLVKDONJSA-N 5-bromo-n-[(6r)-1-ethyl-4-methyl-1,4-diazepan-6-yl]-2-methoxy-6-(methylamino)pyridine-3-carboxamide Chemical compound C1N(CC)CCN(C)C[C@H]1NC(=O)C1=CC(Br)=C(NC)N=C1OC FKDXBULKZKICQO-LLVKDONJSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940123603 Dopamine D2 receptor antagonist Drugs 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000003474 anti-emetic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000442 dopamine 2 receptor blocking agent Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
A találmány az (I) képletű vegyületre és ennek gyógyászatilagelfőgadható savaddíciós sóira vőnatkőzik. A találmány szerintivegyület kiváló antiemetikűs hatású pőtens szerőtőnin S3 és dőpamin D2receptőr antagőnista hatására tekintettel, így felhasználhatókülönböző megbetegedésekkel és hatóanyagők beadásával együttjárógasztrőintesztinális szimptómák kezelésére vagy megelőzésére. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP07212495 | 1995-07-28 | ||
PCT/JP1996/002053 WO1997005129A1 (fr) | 1995-07-28 | 1996-07-23 | (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, son procede d'obtention et medicament le contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9901208A2 true HUP9901208A2 (hu) | 2000-04-28 |
HUP9901208A3 HUP9901208A3 (en) | 2002-10-28 |
Family
ID=16623612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9901208A HUP9901208A3 (en) | 1995-07-28 | 1996-07-23 | (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methyl-amino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same |
Country Status (25)
Country | Link |
---|---|
US (1) | US5945415A (hu) |
EP (1) | EP0855397B1 (hu) |
KR (1) | KR19990028395A (hu) |
CN (1) | CN1096459C (hu) |
AT (1) | ATE201021T1 (hu) |
AU (1) | AU700635B2 (hu) |
BR (1) | BR9609691A (hu) |
CA (1) | CA2228056A1 (hu) |
CZ (1) | CZ290442B6 (hu) |
DE (1) | DE69612753T2 (hu) |
DK (1) | DK0855397T3 (hu) |
ES (1) | ES2156616T3 (hu) |
GR (1) | GR3036089T3 (hu) |
HK (1) | HK1018049A1 (hu) |
HU (1) | HUP9901208A3 (hu) |
IL (1) | IL122753A (hu) |
MX (1) | MX9800620A (hu) |
NO (1) | NO312964B1 (hu) |
NZ (1) | NZ312799A (hu) |
PL (1) | PL184073B1 (hu) |
PT (1) | PT855397E (hu) |
RU (1) | RU2156248C2 (hu) |
SK (1) | SK282044B6 (hu) |
TR (1) | TR199800165T1 (hu) |
WO (1) | WO1997005129A1 (hu) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19650778C2 (de) * | 1996-12-06 | 2001-01-04 | Asta Medica Ag | Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie |
US20040048874A1 (en) * | 2001-05-22 | 2004-03-11 | Bardsley Hazel Judith | New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine |
GB0216027D0 (en) * | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
ITBO20020198A1 (it) * | 2002-04-12 | 2003-10-13 | Univ Bologna | Derivati 2 , 5 bis diammino 1 , 4 benzochenionici utili per il trattamento della malattia di alzheimer , metodo per la loro preparazione ed |
ES2285407T3 (es) * | 2003-01-13 | 2007-11-16 | Dynogen Pharmaceuticals Inc. | Metodo para el tratamiento de nauseas, vomitos, arcadas o cualquiera de sus combinaciones. |
KR20050111318A (ko) * | 2003-01-13 | 2005-11-24 | 다이노젠 파마세우티컬스, 인코포레이티드 | 기능성 장 질환을 치료하는 방법 |
US6846823B2 (en) * | 2003-04-04 | 2005-01-25 | Dynogen Pharmaceuticals, Inc. | Method of treating lower urinary tract disorders |
US20060293309A1 (en) * | 2005-03-28 | 2006-12-28 | Dynogen Pharmaceuticals, Inc. | Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors |
US20120010401A1 (en) | 2009-03-31 | 2012-01-12 | Zeria Pharmaceutical Co., Ltd. | Method for manufacturing 1,5-benzodiazepine derivative |
JP5858917B2 (ja) | 2010-08-26 | 2016-02-10 | 興和株式会社 | イソキノリン誘導体又はその塩の新規製造方法 |
WO2015114608A1 (en) * | 2014-02-03 | 2015-08-06 | Mylan Laboratories Ltd | Processes for the preparation of intermediates of raltegravir |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166341A (en) * | 1988-07-29 | 1992-11-24 | Dainippon Pharmaceutical Co., Ltd. | 6-amino-1,4-hexahydro-1H-diazepine derivatives |
US5017573A (en) * | 1988-07-29 | 1991-05-21 | Dainippon Pharmaceutical Co., Ltd. | Indazole-3-carboxylic acid derivatives |
JPH03223265A (ja) * | 1990-01-26 | 1991-10-02 | Dainippon Pharmaceut Co Ltd | 環状ジアミン誘導体 |
JPH04210970A (ja) * | 1990-01-26 | 1992-08-03 | Dainippon Pharmaceut Co Ltd | ベンズアミド誘導体及びその中間体 |
PT100990A (pt) * | 1991-10-24 | 1994-01-31 | Smithkline Beecham Plc | Derivados de piridina e sua utilizacao como substancia terapeutica |
-
1996
- 1996-07-23 AT AT96924189T patent/ATE201021T1/de not_active IP Right Cessation
- 1996-07-23 RU RU98103388/04A patent/RU2156248C2/ru not_active IP Right Cessation
- 1996-07-23 IL IL12275396A patent/IL122753A/xx not_active IP Right Cessation
- 1996-07-23 DK DK96924189T patent/DK0855397T3/da active
- 1996-07-23 PT PT96924189T patent/PT855397E/pt unknown
- 1996-07-23 WO PCT/JP1996/002053 patent/WO1997005129A1/ja not_active Application Discontinuation
- 1996-07-23 BR BR9609691A patent/BR9609691A/pt not_active Application Discontinuation
- 1996-07-23 CN CN96195988A patent/CN1096459C/zh not_active Expired - Fee Related
- 1996-07-23 KR KR1019970709711A patent/KR19990028395A/ko not_active Application Discontinuation
- 1996-07-23 MX MX9800620A patent/MX9800620A/es not_active IP Right Cessation
- 1996-07-23 PL PL96324749A patent/PL184073B1/pl unknown
- 1996-07-23 EP EP96924189A patent/EP0855397B1/en not_active Expired - Lifetime
- 1996-07-23 SK SK93-98A patent/SK282044B6/sk unknown
- 1996-07-23 CA CA002228056A patent/CA2228056A1/en not_active Abandoned
- 1996-07-23 HU HU9901208A patent/HUP9901208A3/hu unknown
- 1996-07-23 AU AU64717/96A patent/AU700635B2/en not_active Ceased
- 1996-07-23 NZ NZ312799A patent/NZ312799A/en unknown
- 1996-07-23 CZ CZ1998230A patent/CZ290442B6/cs not_active IP Right Cessation
- 1996-07-23 US US09/000,468 patent/US5945415A/en not_active Expired - Fee Related
- 1996-07-23 TR TR1998/00165T patent/TR199800165T1/xx unknown
- 1996-07-23 ES ES96924189T patent/ES2156616T3/es not_active Expired - Lifetime
- 1996-07-23 DE DE69612753T patent/DE69612753T2/de not_active Expired - Fee Related
-
1998
- 1998-01-26 NO NO19980333A patent/NO312964B1/no not_active IP Right Cessation
- 1998-12-08 HK HK98112940A patent/HK1018049A1/xx not_active IP Right Cessation
-
2001
- 2001-06-19 GR GR20010400934T patent/GR3036089T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9612291A (pt) | Forma de dosagem sólida bioadesiva | |
HUP0302571A2 (hu) | Szerves vegyületek keverékét tartalmazó gyógyszerkészítmény légúti betegségek kezelésére | |
IL149496A (en) | Pharmaceutical compositions and their use in the treatment of the gastrointestinal tract | |
SE0104341D0 (sv) | New use | |
HUP9901208A2 (hu) | (R)-5-Bróm-n-(1-etil-4-metil-hexahidro-1H-1,4-diazepin-6-il)-2-metoxi-6-(metil-amino)-3-piridin-karboxamid, eljárás előállítására és ezt a vegyületet tartalmazó gyógyászati készítmény | |
NO304113B1 (no) | Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament | |
HUP0301390A2 (hu) | Valzartánt tartalmazó orális gyógyászati készítmény | |
SE0102055D0 (sv) | New Compounds | |
SE0102440D0 (sv) | New compound | |
RO117760B1 (ro) | Metodă pentru tratamentul unei afecţiuni de neurotransmisie serotoninergică defectivă | |
GR3019274T3 (en) | Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use | |
BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
HUP0300863A2 (hu) | N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény | |
HUP9900227A2 (hu) | AII-receptor antagonisták új gyógyszerészeti felhasználása | |
NO175679C (no) | Analogifremgangsmåte for fremstilling av en terapeutisk aktiv, substituert aminforbindelse | |
MY133508A (en) | Polymorphs of a crystalline azobicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions | |
IL126795A (en) | Pharmaceutical compositions for the treatment of substance abuse disorders comprising pyridyl- and pyrimidyl-piperazines | |
CA2409845A1 (en) | Active substance combination containing a compound with an opioid effect and at least one further compound of formula i | |
KR950700063A (ko) | 외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress) | |
EE200100193A (et) | 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises | |
NO974197L (no) | Fremgangsmåte til fremstilling av estere av anhydroecgonin | |
KR940002268A (ko) | 21-클로로-프레그난 유도체 | |
MD940244A (ro) | Derivaţi noi ai tetrazolului, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor | |
MX9205204A (es) | Composicion farmaceutica que comprende compuestos antagonistas del receptor 5-hidroxitriptamina |